Mondelez International
MDLZ
$62.42
+1.28%
Mondelez International, Inc. is a global snacking powerhouse, operating primarily in the biscuits, chocolate, gum/candy, and beverage categories, with well-known brands like Oreo, Cadbury, and Chips Ahoy. As a market leader in the global snack industry, the company derives about one-third of its revenue from developing markets, 40% from Europe, and over a quarter from North America. The current investor narrative centers on Mondelez's ability to sustain growth in a challenging consumer environment, with recent attention on its reliable dividend (yielding ~3.6%) and its strategic focus on core snacking categories, while navigating input cost inflation and currency headwinds. The stock has shown resilience with a 14.2% YTD gain, but underperformed the broader market over the past year, prompting debate about its growth prospects versus its defensive appeal.…
MDLZ
Mondelez International
$62.42
Related headlines
Investment Opinion: Should I buy MDLZ Today?
Based on the analysis, MDLZ is rated a 'Buy' with a thesis that its accelerating revenue growth and attractive forward valuation offer upside, while its defensive nature provides downside support. The consensus rating is 'Buy' with an average target of $69.13, implying a 12.8% upside from the current price of $61.28. Supporting evidence includes 8.2% YoY revenue growth in Q1 2026, a forward PE of 18.2x (17% discount to industry), a 3.6% dividend yield, and a low beta of 0.40. However, risks include margin compression, high debt, and underperformance vs. the market. This 'Buy' would be downgraded to 'Hold' if gross margins fall below 25% or revenue growth decelerates below 5%, and upgraded to 'Strong Buy' if margins recover above 30% and forward PE remains below 20x. Overall, the stock is fairly valued relative to its growth prospects, but not a bargain.
Sign up to view all
MDLZ 12-Month Price Forecast
The AI assessment is neutral with medium confidence. Mondelez's revenue acceleration and forward valuation discount are positive, but margin compression and high debt temper enthusiasm. The stock's low beta and dividend yield provide downside support, but the lack of clear catalysts for margin recovery limits upside. If gross margins stabilize and revenue growth continues, the stance could upgrade to bullish; if margins deteriorate further, it would downgrade to bearish.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Mondelez International's 12-month outlook, with a consensus price target around $69.13 and implied upside of +10.8% versus the current price.
Average Target
$69.13
0 analysts
Implied Upside
+10.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$55 - $77
Analyst target range
Mondelez is covered by 23 analysts, with a consensus recommendation of 'Buy' (mean rating of 1.96, where 1 is strong buy and 5 is sell). The average price target is $69.13, implying an upside of +12.8% from the current price of $61.28. The distribution includes 10 analysts with Overweight/Buy ratings and 3 with Neutral/Hold, indicating a bullish tilt. The low target is $55.00, suggesting a potential downside of -10.2%, while the high target is $77.00, implying a +25.7% upside. The wide range between low and high targets (22 points) reflects uncertainty about Mondelez's growth trajectory and margin recovery. Recent institutional actions have been mostly reaffirmations of Overweight/Buy ratings, with one downgrade from Rothschild & Co from Buy to Neutral in March 2026, but overall sentiment remains positive.
Drowning in data?
Find the real signal!
Bulls vs Bears: MDLZ Investment Factors
Mondelez presents a mixed picture: strong revenue acceleration and a compelling forward valuation are offset by margin compression and a rich trailing PE. The bull case is supported by analyst optimism and defensive characteristics, while the bear case highlights cost pressures and relative underperformance. Currently, the bull case has slightly stronger evidence given the forward discount and growth acceleration, but the key tension is whether margin recovery will materialize to justify the earnings growth implied by the forward PE. If margins stabilize and growth continues, the stock could re-rate higher; if not, the premium could compress.
Bullish
- Accelerating Revenue Growth: Q1 2026 revenue grew 8.2% YoY to $10.08B, a sharp acceleration from 0.6% growth in Q1 2025. This indicates improving top-line momentum driven by pricing and volume recovery.
- Attractive Forward Valuation: Forward PE of 18.2x is at a 17% discount to the industry average of 22x, suggesting the market expects significant earnings growth. This is supported by analyst EPS estimates of $4.22 for the next fiscal year.
- Strong Analyst Consensus: With a consensus 'Buy' rating and an average price target of $69.13, the stock implies a 12.8% upside from the current price of $61.28. 10 analysts rate it Overweight/Buy, reflecting broad optimism.
- Resilient Dividend Income: MDLZ offers a reliable dividend yield of 3.6% with a quarterly payout of $0.50 per share. This provides a solid income cushion and attracts defensive investors, supporting the stock's downside.
Bearish
- Margin Compression Pressures: Gross margin fell to 27.8% in Q1 2026 from 32.7% in Q2 2025, reflecting input cost inflation and currency headwinds. This has pressured profitability despite revenue growth.
- High Trailing PE Premium: Trailing PE of 28.5x is 30% above the industry average of 22x, indicating the stock is not cheap on historical earnings. This premium could compress if growth disappoints.
- Underperformance vs Market: Over the past year, MDLZ returned only 0.6% versus the S&P 500's 18.7%, underperforming by 18 percentage points. This suggests investors are favoring growth over defensive staples.
- Elevated Debt Levels: Debt-to-equity ratio of 0.87 and a current ratio of 0.59 indicate high leverage and potential liquidity concerns. Interest expenses of $148M in Q1 2026 add to fixed costs.
MDLZ Technical Analysis
Mondelez's stock is in a broad uptrend, with a 1-year price change of +0.6%, though this lags the S&P 500's +18.7% gain. The current price of $61.28 sits at 92% of its 52-week range (low $51.20, high $66.65), indicating the stock is near the upper end of its yearly range, suggesting positive momentum but also potential overextension. The 6-month change of +4.9% and YTD change of +14.2% confirm a recovery from earlier lows, with the stock having rebounded from a 52-week low in March 2026.
Beta
0.40
0.40x market volatility
Max Drawdown
-20.0%
Largest decline past year
52-Week Range
$51-$67
Price range past year
Annual Return
-0.2%
Cumulative gain past year
| Period | MDLZ Return | S&P 500 |
|---|---|---|
| 1m | +1.4% | -1.4% |
| 3m | -1.5% | +3.3% |
| 6m | +13.7% | +15.1% |
| 1y | -0.2% | +17.2% |
| ytd | +16.3% | +11.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MDLZ Fundamental Analysis
In Q1 2026 (ending March 31, 2026), Mondelez reported revenue of $10.08 billion, up 8.2% year-over-year, with a net income of $560 million, reflecting a net margin of 5.6%. This revenue growth is a notable acceleration from the prior year's Q1 growth of 0.6% (revenue of $9.31 billion in Q1 2025), indicating improving top-line momentum. However, the net income of $560 million is lower than the $743 million reported in Q3 2025, showing quarterly volatility, but the trailing twelve-month net income remains positive. The company's gross margin in Q1 2026 was 27.8%, down from 32.7% in Q2 2025, reflecting cost pressures, but operating income of $860 million (8.5% operating margin) shows the company remains solidly profitable.
Quarterly Revenue
$10.1B
2026-03
Revenue YoY Growth
+8.2%
YoY Comparison
Gross Margin
27.8%
Latest Quarter
Free Cash Flow
$2.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MDLZ Overvalued?
Given Mondelez's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 28.5x, while the forward PE is 18.2x, indicating the market expects significant earnings growth (the forward PE is based on estimated EPS of $4.22 for the next fiscal year). This gap between trailing and forward PE suggests the market is pricing in a recovery in earnings from the depressed Q1 2026 level. Compared to the industry average PE of 22x (as per valuation data), Mondelez trades at a 30% premium on a trailing basis, but on a forward basis, it is at a 17% discount, reflecting expectations of above-average growth. Historically, Mondelez's PE has ranged from 11.4x (Q4 2024) to 54.7x (Q1 2025), with the current trailing PE of 28.5x sitting near the middle of that range, suggesting it is not excessively valued relative to its own history.
PE
28.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 11x~39x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Mondelez carries a debt-to-equity ratio of 0.87, indicating significant leverage that increases interest expense and financial risk. The current ratio of 0.59 suggests potential liquidity challenges, as current liabilities exceed current assets. Gross margin has contracted from 32.7% in Q2 2025 to 27.8% in Q1 2026, reflecting input cost inflation and currency headwinds, which could further pressure net income if not managed. Additionally, the payout ratio of 101.5% indicates that dividends exceed earnings, which may not be sustainable if earnings decline, potentially forcing a dividend cut or increased borrowing.
FAQ
Key risks include: 1) Margin compression from input cost inflation, as seen in the gross margin drop from 32.7% to 27.8% over the past year. 2) High debt levels with a debt-to-equity ratio of 0.87, which could strain cash flows if interest rates rise. 3) Underperformance relative to the market, with a 1-year return of 0.6% vs. the S&P 500's 18.7%, indicating potential sector rotation away from staples. 4) Dividend sustainability is questionable with a payout ratio of 101.5%, which may force a cut if earnings decline. The most severe risk is a prolonged margin squeeze leading to earnings disappointment and a de-rating.
The 12-month forecast is moderately positive. The base case (50% probability) targets $64-69, aligning with the average analyst target of $69.13, assuming revenue growth of 5-7% and stable margins. The bull case (30% probability) targets $69-77, driven by margin recovery and stronger growth. The bear case (20% probability) targets $51-55, if margins deteriorate and growth stalls. The most likely scenario is the base case, with the stock reaching the average target, but investors should watch margin trends closely.
MDLZ is fairly valued on a forward basis but appears overvalued on trailing earnings. The forward PE of 18.2x is 17% below the industry average of 22x, indicating the market expects earnings growth. However, the trailing PE of 28.5x is 30% above the industry, reflecting past earnings that were depressed by margin compression. Historically, the PE has ranged from 11.4x to 54.7x, so the current trailing PE is in the middle. The market is pricing in a recovery in earnings, which is plausible given the revenue acceleration.
MDLZ is a good buy for investors seeking a defensive, income-generating stock with moderate growth potential. The consensus 'Buy' rating and average price target of $69.13 imply a 12.8% upside, while the forward PE of 18.2x is below the industry average, suggesting reasonable valuation. However, the trailing PE of 28.5x and margin pressures present risks. It is particularly suitable for long-term investors who value dividend stability and low volatility, but growth-oriented investors may find better opportunities elsewhere.
MDLZ is better suited for long-term investment due to its defensive nature, low beta of 0.40, and reliable dividend. Short-term trading may be limited by its low volatility and lack of strong catalysts. The stock's growth stage is mature, with earnings visibility moderate, but its dividend yield of 3.6% provides a return cushion. A suggested minimum holding period is 3-5 years to ride out margin cycles and benefit from dividend compounding. For short-term traders, the stock may offer limited opportunities, but it can serve as a stable core holding.
